Abstract | OBJECTIVE: To compare the effects of 2.5 mg letrozole with those of 1 mg anastrazole daily on the hormonal and semen profiles of a subset of infertile men with low T/E(2) ratios. DESIGN: Prospective, nonrandomized study. SETTING: Reproductive medicine clinic. PATIENT(S): The study group consisted of 29 infertile men with a low serum T/E(2) ratio (<10). INTERVENTION(S): Patients were divided into two groups. Group A included 15 patients treated with 2.5 mg letrozole orally once daily for 6 months, and Group B consisted of 14 patients treated with 1 mg anastrazole orally every day for 6 months. MAIN OUTCOME MEASURE(S): Hormonal evaluation included measurement of serum FSH, LH, PRL, T, and E(2). In all sperm analyses pretreatment and posttreatment total motile sperm counts (ejaculate volume × concentration × motile fraction) were evaluated. RESULT(S): CONCLUSION(S): This study suggests that some men with severe oligospermia, low T levels, and normal gonadotropin concentration may have a treatable endocrinopathy.
|
Authors | Odysseas Gregoriou, Panagiotis Bakas, Charalampos Grigoriadis, Maria Creatsa, Dimitrios Hassiakos, Georgios Creatsas |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 98
Issue 1
Pg. 48-51
(Jul 2012)
ISSN: 1556-5653 [Electronic] United States |
PMID | 22579129
(Publication Type: Clinical Trial, Journal Article)
|
Copyright | Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Aromatase Inhibitors
- Hormones
- Nitriles
- Triazoles
- Anastrozole
- Testosterone
- Estradiol
- Letrozole
|
Topics |
- Adult
- Anastrozole
- Aromatase Inhibitors
(adverse effects, pharmacology, therapeutic use)
- Estradiol
(analysis, blood)
- Hormones
(blood, metabolism)
- Humans
- Infertility, Male
(blood, drug therapy, pathology)
- Letrozole
- Male
- Nitriles
(adverse effects, pharmacology, therapeutic use)
- Organ Size
(drug effects)
- Semen Analysis
- Testis
(drug effects, pathology)
- Testosterone
(analysis, blood)
- Triazoles
(adverse effects, pharmacology, therapeutic use)
|